Moreover, treatment with cHL cell SN conserved and enhanced the MΦ-2 phenotype in MΦM-CSF, as also demonstrated by the upregulation of CD163 known to promote an anti-inflammatory microenvironment [49] and of CD206, which acts pro-angiogenic [50] and thus might promote tumor growth. Here, MRC1 is linked to neoplasm.